{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:04:56Z","timestamp":1769879096441,"version":"3.49.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11686-022-00620-7","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T03:37:27Z","timestamp":1666669047000},"page":"1487-1499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of Mesenchymal Stem Cells Therapy in Parasitic Infections: Are Anti-parasitic Drugs Combined with MSCs More Effective?"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1930-2346","authenticated-orcid":false,"given":"Mehdi","family":"Kian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-1710","authenticated-orcid":false,"given":"Somayeh","family":"Mirzavand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8109-0332","authenticated-orcid":false,"given":"Sedigheh","family":"Sharifzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3602-7710","authenticated-orcid":false,"given":"Tahereh","family":"Kalantari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2246-4901","authenticated-orcid":false,"given":"Marzieh","family":"Ashrafmansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4182-3930","authenticated-orcid":false,"given":"Fatemeh","family":"Nasri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"620_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.15283\/ijsc17052","volume":"11","author":"F Nasri","year":"2018","unstructured":"Nasri F, Mohtasebi MS, Hashemi E, Zarrabi M, Gholijani N, Sarvestani EK (2018) Therapeutic efficacy of mesenchymal stem cells and mesenchymal stem cells-derived neural progenitors in experimental autoimmune encephalomyelitis. Int J Stem Cells 11:68\u201377.\u00a0https:\/\/doi.org\/10.15283\/ijsc17052","journal-title":"Int J Stem Cells"},{"key":"620_CR2","doi-asserted-by":"publisher","first-page":"457614","DOI":"10.1155\/2014\/457614","volume":"2014","author":"MS Mohtasebi","year":"2014","unstructured":"Mohtasebi MS, Nasri F, Kamali Sarvestani E (2014) Effect of DiD carbocyanine dye labeling on immunoregulatory function and differentiation of mice mesenchymal stem cells. Stem Cells Int 2014:457614.\u00a0https:\/\/doi.org\/10.1155\/2014\/457614","journal-title":"Stem Cells Int"},{"issue":"1","key":"620_CR3","doi-asserted-by":"publisher","first-page":"e12712","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J (2020) Immune modulation by mesenchymal stem cells. Cell Prolif 53(1):e12712. https:\/\/doi.org\/10.1111\/cpr.12712","journal-title":"Cell Prolif"},{"key":"620_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-23421-8_2","author":"N Haque","year":"2019","unstructured":"Haque N, Ramasamy TS, Kasim NHA (2019) Mechanisms of mesenchymal stem cells for autoimmune disease treatment. Stem cell transplantation for autoimmune diseases and inflammation. Stem Cells in Clin Appl. https:\/\/doi.org\/10.1007\/978-3-030-23421-8_2","journal-title":"Stem Cells in Clin Appl"},{"key":"620_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.semcancer.2019.06.003","volume":"60","author":"M Timaner","year":"2020","unstructured":"Timaner M, Tsai KK, Shaked Y (2020) The multifaceted role of mesenchymal stem cells in cancer. Semin Cancer Biol 60:225\u2013237.\u00a0https:\/\/doi.org\/10.1016\/j.semcancer.2019.06.003","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"620_CR6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1530\/JME-17-0117","volume":"4","author":"LT-T Dang","year":"2017","unstructured":"Dang LT-T, Phan NK, Truong KD (2017) Mesenchymal stem cells for diabetes mellitus treatment: new advances. Biomed Res Ther 4(1):1062\u20131081.\u00a0https:\/\/doi.org\/10.1530\/JME-17-0117","journal-title":"Biomed Res Ther"},{"issue":"6","key":"620_CR7","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s12015-021-10191-1","volume":"17","author":"M Kalkal","year":"2021","unstructured":"Kalkal M, Tiwari M, Thakur RS, Awasthi V, Pande V, Chattopadhyay D et al (2021) Mesenchymal stem cells: a novel therapeutic approach to enhance protective immunomodulation and erythropoietic recovery in Malaria. Stem Cell Rev Rep 17(6):1993\u20132002. https:\/\/doi.org\/10.1007\/s12015-021-10191-1","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"620_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.21608\/EJH.2017.4663","volume":"40","author":"MH Raafat","year":"2017","unstructured":"Raafat MH, Abdel Gawad S, Fikry H (2017) Histological study on the possible therapeutic role of bone marrow derived mesenchymal stem cells in a model of Schistosoma mansoni infestation of spleen of mice. Egypt J Histol 40(3):388\u2013404.\u00a0https:\/\/doi.org\/10.21608\/EJH.2017.4663","journal-title":"Egypt J Histol"},{"key":"620_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.22074\/cellj.2020.6838","volume":"22","author":"E Zanganeh","year":"2020","unstructured":"Zanganeh E, Soudi S, Zavaran Hosseini A (2020) Intralesional Injection of Mouse Mesenchymal Stem Cells Reduces IL-10 Production and Parasite Burden in L. major Infected BALB\/c Mice. Cell J 22:11\u201318.\u00a0https:\/\/doi.org\/10.22074\/cellj.2020.6838","journal-title":"Cell J"},{"issue":"1","key":"620_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s13071-015-1050-8","volume":"8","author":"H Sady","year":"2015","unstructured":"Sady H, Al-Mekhlafi HM, Atroosh WM, Al-Delaimy AK, Nasr NA, Dawaki S et al (2015) Knowledge, attitude, and practices towards schistosomiasis among rural population in Yemen. Parasit Vectors 8(1):436. https:\/\/doi.org\/10.1186\/s13071-015-1050-8","journal-title":"Parasit Vectors"},{"issue":"9","key":"620_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185245","volume":"12","author":"S Roure","year":"2017","unstructured":"Roure S, Valerio L, Perez-Quilez O, Fernandez-Rivas G, Martinez-Cuevas O, Alcantara-Roman A et al (2017) Epidemiological, clinical, diagnostic and economic features of an immigrant population of chronic schistosomiasis sufferers with long-term residence in a non-endemic country (North Metropolitan area of Barcelona, 2002\u20132016). PLoS ONE 12(9):e0185245. https:\/\/doi.org\/10.1371\/journal.pone.0185245","journal-title":"PLoS ONE"},{"issue":"26","key":"620_CR12","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1812165","volume":"381","author":"AK Deol","year":"2019","unstructured":"Deol AK, Fleming FM, Calvo-Urbano B, Walker M, Bucumi V, Gnandou I et al (2019) Schistosomiasis-assessing progress toward the 2020 and 2025 global goals. N Engl J Med 381(26):2519\u20132528. https:\/\/doi.org\/10.1056\/NEJMoa1812165","journal-title":"N Engl J Med"},{"issue":"8","key":"620_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008635","volume":"14","author":"VHS Miranda","year":"2020","unstructured":"Miranda VHS, Gomes TR, Eller DE, Ferraz LCN, Chaves AT, Bicalho KA et al (2020) Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment. PLoS Negl Trop Dis 14(8):e0008635. https:\/\/doi.org\/10.1371\/journal.pntd.0008635","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"620_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s12639-018-0997-8","volume":"42","author":"MH Hegab","year":"2018","unstructured":"Hegab MH, Abd-Allah SH, Badawey MS, Saleh AA, Metwally AS, Fathy GM et al (2018) Therapeutic potential effect of bone marrow-derived mesenchymal stem cells on chronic liver disease in murine Schistosomiasis Mansoni. J Parasit Dis 42(2):277\u2013286. https:\/\/doi.org\/10.1007\/s12639-018-0997-8","journal-title":"J Parasit Dis"},{"issue":"1","key":"620_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4155\/fmc-2017-0112","volume":"10","author":"EM Lago","year":"2018","unstructured":"Lago EM, Xavier RP, Teixeira TR, Silva LM, da Silva Filho AA, de Moraes J (2018) Antischistosomal agents: state of art and perspectives. Future Med Chem 10(1):89\u2013120. https:\/\/doi.org\/10.4155\/fmc-2017-0112","journal-title":"Future Med Chem"},{"issue":"5","key":"620_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2174\/1389557513666131119204558","volume":"17","author":"LX Liu","year":"2017","unstructured":"Liu LX, Li-Li J, Qiong C, Xiao-Lin F (2017) Recent advances in the synthesis of antischistosomal drugs and agents. Mini Rev Med Chem 17(5):467\u2013484. https:\/\/doi.org\/10.2174\/1389557513666131119204558","journal-title":"Mini Rev Med Chem"},{"issue":"5","key":"620_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1258\/ebm.2012.011362","volume":"237","author":"H Xu","year":"2012","unstructured":"Xu H, Qian H, Zhu W, Zhang X, Yan Y, Mao F et al (2012) Mesenchymal stem cells relieve fibrosis of Schistosoma japonicum-induced mouse liver injury. Exp Biol Med (Maywood) 237(5):585\u2013592. https:\/\/doi.org\/10.1258\/ebm.2012.011362","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"620_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11686-020-00267-2","volume":"66","author":"M Alsulami","year":"2021","unstructured":"Alsulami M, Abdel-Gaber R (2021) Cell therapy as a new approach on hepatic fibrosis of murine model of Schistosoma mansoni-infection. Acta Parasitol 66(1):136\u2013145. https:\/\/doi.org\/10.1007\/s11686-020-00267-2","journal-title":"Acta Parasitol"},{"issue":"2","key":"620_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00436-013-3689-4","volume":"113","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Mi JY, Rui YJ, Xu YL, Wang W (2014) Stem cell therapy for the treatment of parasitic infections: is it far away? Parasitol Res 113(2):607\u2013612. https:\/\/doi.org\/10.1007\/s00436-013-3689-4","journal-title":"Parasitol Res"},{"key":"620_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1539-8","volume":"11","author":"L Dong","year":"2020","unstructured":"Dong L, Pu Y, Chen X, Qi X, Zhang L, Xu L et al (2020) hUCMSC-extracellular vesicles downregulated hepatic stellate cell activation and reduced liver injury in S. Japonicum-infected mice. Stem Cell Research Therapy 11:1\u201311.\u00a0https:\/\/doi.org\/10.1186\/s13287-019-1539-8","journal-title":"Stem Cell Research Therapy"},{"issue":"1","key":"620_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13287-020-01735-2","volume":"11","author":"C Liu","year":"2020","unstructured":"Liu C, Zhang YS, Chen F, Wu XY, Zhang BB, Wu ZD et al (2020) Immunopathology in schistosomiasis is regulated by TLR2,4- and IFN-gamma-activated MSC through modulating Th1\/Th2 responses. Stem Cell Res Ther 11(1):217. https:\/\/doi.org\/10.1186\/s13287-020-01735-2","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"620_CR22","doi-asserted-by":"publisher","first-page":"21005","DOI":"10.1038\/srep21005","volume":"6","author":"OA Hammam","year":"2016","unstructured":"Hammam OA, Elkhafif N, Attia YM, Mansour MT, Elmazar MM, Abdelsalam RM et al (2016) Wharton\u2019s jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis. Sci Rep 6(1):21005. https:\/\/doi.org\/10.1038\/srep21005","journal-title":"Sci Rep"},{"issue":"1","key":"620_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.46582\/jsrm.0801005","volume":"8","author":"M Abdel Aziz","year":"2012","unstructured":"Abdel Aziz M, Atta H, Roshdy N, Rashed L, Sabry D, Hassouna A et al (2012) Amelioration of murine schistosoma mansoni induced liver fibrosis by mesenchymal stem cells. J Stem Cells Regen Med 8(1):28\u201334. https:\/\/doi.org\/10.46582\/jsrm.0801005","journal-title":"J Stem Cells Regen Med"},{"issue":"4","key":"620_CR24","doi-asserted-by":"publisher","first-page":"e00019","DOI":"10.1128\/CMR.00019-19","volume":"32","author":"XZ Su","year":"2019","unstructured":"Su XZ, Lane KD, Xia L, Sa JM, Wellems TE (2019) Plasmodium genomics and genetics: new insights into malaria pathogenesis, drug resistance, epidemiology, and evolution. Clin Microbiol Rev 32(4):e00019-19. https:\/\/doi.org\/10.1128\/CMR.00019-19","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"620_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12936-018-2220-x","volume":"17","author":"ML Sadoine","year":"2018","unstructured":"Sadoine ML, Smargiassi A, Ridde V, Tusting LS, Zinszer K (2018) The associations between malaria, interventions, and the environment: a systematic review and meta-analysis. Malar J 17(1):73. https:\/\/doi.org\/10.1186\/s12936-018-2220-x","journal-title":"Malar J"},{"issue":"1","key":"620_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13287-015-0138-6","volume":"6","author":"W Wang","year":"2015","unstructured":"Wang W, Qian H, Cao J (2015) Stem cell therapy: a novel treatment option for cerebral malaria? Stem Cell Res Ther 6(1):141. https:\/\/doi.org\/10.1186\/s13287-015-0138-6","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"620_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2005.08.006","volume":"23","author":"M Walther","year":"2005","unstructured":"Walther M, Tongren JE, Andrews L, Korbel D, King E, Fletcher H et al (2005) Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23(3):287\u2013296. https:\/\/doi.org\/10.1016\/j.immuni.2005.08.006","journal-title":"Immunity"},{"issue":"1","key":"620_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13287-015-0093-2","volume":"6","author":"MC Souza","year":"2015","unstructured":"Souza MC, Silva JD, Padua TA, Torres ND, Antunes MA, Xisto DG et al (2015) Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria. Stem Cell Res Ther 6(1):102. https:\/\/doi.org\/10.1186\/s13287-015-0093-2","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"620_CR29","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1002\/eji.201242882","volume":"43","author":"RS Thakur","year":"2013","unstructured":"Thakur RS, Tousif S, Awasthi V, Sanyal A, Atul PK, Punia P et al (2013) Mesenchymal stem cells play an important role in host protective immune responses against malaria by modulating regulatory T cells. Eur J Immunol 43(8):2070\u20132077. https:\/\/doi.org\/10.1002\/eji.201242882","journal-title":"Eur J Immunol"},{"issue":"1","key":"620_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41420-020-00363-2","volume":"6","author":"RS Thakur","year":"2020","unstructured":"Thakur RS, Awasthi V, Sanyal A, Chatterjee S, Rani S, Chauhan R et al (2020) Mesenchymal stem cells protect against malaria pathogenesis by reprogramming erythropoiesis in the bone marrow. Cell Death Discov 6(1):125. https:\/\/doi.org\/10.1038\/s41420-020-00363-2","journal-title":"Cell Death Discov"},{"issue":"2","key":"620_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1017\/S0022149X0928936X","volume":"83","author":"A Hemphill","year":"2009","unstructured":"Hemphill A, Muller J (2009) Alveolar and cystic echinococcosis: towards novel chemotherapeutical treatment options. J Helminthol 83(2):99\u2013111. https:\/\/doi.org\/10.1017\/S0022149X0928936X","journal-title":"J Helminthol"},{"issue":"10","key":"620_CR32","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/pathogens10101326","volume":"10","author":"TFE Barth","year":"2021","unstructured":"Barth TFE, Casulli A (2021) Morphological characteristics of alveolar and cystic echinococcosis lesions in human liver and bone. Pathogens 10(10):1326. https:\/\/doi.org\/10.3390\/pathogens10101326","journal-title":"Pathogens"},{"issue":"2","key":"620_CR33","doi-asserted-by":"publisher","first-page":"e00075","DOI":"10.1128\/CMR.00075-18","volume":"32","author":"H Wen","year":"2019","unstructured":"Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W et al (2019) Echinococcosis: advances in the 21st Century. Clin Microbiol Rev 32(2):e00075-e118. https:\/\/doi.org\/10.1128\/CMR.00075-18","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"620_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/bmb\/ldx033","volume":"124","author":"A Diaz","year":"2017","unstructured":"Diaz A (2017) Immunology of cystic echinococcosis (hydatid disease). Br Med Bull 124(1):121\u2013133. https:\/\/doi.org\/10.1093\/bmb\/ldx033","journal-title":"Br Med Bull"},{"issue":"2","key":"620_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cr.2019.11.001","volume":"8","author":"FAM Abo-Aziza","year":"2019","unstructured":"Abo-Aziza FAM, Zaki AKA, Abo El-Maaty AM (2019) Bone marrow-derived mesenchymal stem cell (BM-MSC): A tool of cell therapy in hydatid experimentally infected rats. Cell Regen 8(2):58\u201371. https:\/\/doi.org\/10.1016\/j.cr.2019.11.001","journal-title":"Cell Regen"},{"issue":"1","key":"620_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010175","volume":"16","author":"N Yang","year":"2022","unstructured":"Yang N, Ma W, Ke Y, Liu H, Chu J, Sun L et al (2022) Transplantation of adipose-derived stem cells ameliorates Echinococcus multilocularis-induced liver fibrosis in mice. PLoS Negl Trop Dis 16(1):e0010175. https:\/\/doi.org\/10.1371\/journal.pntd.0010175","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"620_CR37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.pt.2014.07.003","volume":"30","author":"GM Moreira","year":"2014","unstructured":"Moreira GM, Telmo Pde L, Mendonca M, Moreira AN, McBride AJ, Scaini CJ et al (2014) Human toxocariasis: current advances in diagnostics, treatment, and interventions. Trends Parasitol 30(9):456\u2013464. https:\/\/doi.org\/10.1016\/j.pt.2014.07.003","journal-title":"Trends Parasitol"},{"issue":"7","key":"620_CR38","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1017\/S003118202000044X","volume":"147","author":"EVN Beshay","year":"2020","unstructured":"Beshay EVN, El-Refai SA, Sadek GS, Elbadry AA, Shalan FH, Afifi AF (2020) Mesenchymal stem cells combined with albendazole as a novel therapeutic approach for experimental neurotoxocariasis. Parasitology 147(7):799\u2013809. https:\/\/doi.org\/10.1017\/S003118202000044X","journal-title":"Parasitology"},{"key":"620_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.14202\/vetworld.2021.347-363","volume":"14","author":"FAM Abo-Aziza","year":"2021","unstructured":"Abo-Aziza FAM, Zaki AKA, Alajaji AI, Al Barrak SM (2021) Bone marrow mesenchymal stem cell co-adjuvant therapy with albendazole for managing Toxocara vitulorum-rat model. Vet World 14:347\u2013363.\u00a0https:\/\/doi.org\/10.14202\/vetworld.2021.347-363","journal-title":"Vet World"},{"issue":"2","key":"620_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","volume":"8","author":"S Mann","year":"2021","unstructured":"Mann S, Frasca K, Scherrer S, Henao-Martinez AF, Newman S, Ramanan P et al (2021) A review of Leishmaniasis: Current knowledge and future directions. Curr Trop Med Rep 8(2):121\u2013132. https:\/\/doi.org\/10.1007\/s40475-021-00232-7","journal-title":"Curr Trop Med Rep"},{"key":"620_CR41","doi-asserted-by":"publisher","first-page":"750","DOI":"10.12688\/f1000research.11120.1","volume":"6","author":"E Torres-Guerrero","year":"2017","unstructured":"Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R (2017) Leishmaniasis: a review. F1000Res 6:750.\u00a0https:\/\/doi.org\/10.12688\/f1000research.11120.1","journal-title":"F1000Res"},{"issue":"1","key":"620_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678707.2019.1552853","volume":"7","author":"S Sundar","year":"2018","unstructured":"Sundar S, Chakravarty J, Meena LP (2018) Leishmaniasis: treatment, drug resistance and emerging therapies. Expert Opin Orphan Drugs 7(1):1\u201310. https:\/\/doi.org\/10.1080\/21678707.2019.1552853","journal-title":"Expert Opin Orphan Drugs"},{"issue":"10151","key":"620_CR43","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M (2018) Leishmaniasis Lancet 392(10151):951\u2013970. https:\/\/doi.org\/10.1016\/S0140-6736(18)31204-2","journal-title":"Leishmaniasis Lancet"},{"key":"620_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/815023","author":"JP de Menezes","year":"2015","unstructured":"de Menezes JP, Guedes CE, Petersen AL, Fraga DB, Veras PS (2015) Advances in development of new treatment for Leishmaniasis. Biomed Res Int. https:\/\/doi.org\/10.1155\/2015\/815023","journal-title":"Biomed Res Int"},{"key":"620_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.imlet.2015.12.002","volume":"170","author":"S Dameshghi","year":"2016","unstructured":"Dameshghi S, Zavaran-Hosseini A, Soudi S, Shirazi FJ, Nojehdehi S, Hashemi SM (2016) Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice. Immunol Lett 170:15\u201326. https:\/\/doi.org\/10.1016\/j.imlet.2015.12.002","journal-title":"Immunol Lett"},{"issue":"9","key":"620_CR46","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1002\/jcb.25926","volume":"118","author":"Z Khosrowpour","year":"2017","unstructured":"Khosrowpour Z, Hashemi SM, Mohammadi-Yeganeh S, Soudi S (2017) Pretreatment of mesenchymal stem cells with Leishmania major soluble antigens induce anti-inflammatory properties in mouse peritoneal macrophages. J Cell Biochem 118(9):2764\u20132779. https:\/\/doi.org\/10.1002\/jcb.25926","journal-title":"J Cell Biochem"},{"issue":"3","key":"620_CR47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/intimm\/dxx075","volume":"30","author":"M Rossi","year":"2018","unstructured":"Rossi M, Fasel N (2018) How to master the host immune system? Leishmania parasites have the solutions! Int Immunol 30(3):103\u2013111. https:\/\/doi.org\/10.1093\/intimm\/dxx075","journal-title":"Int Immunol"},{"issue":"8","key":"620_CR48","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/microorganisms8081201","volume":"8","author":"NM Ikeogu","year":"2020","unstructured":"Ikeogu NM, Akaluka GN, Edechi CA, Salako ES, Onyilagha C, Barazandeh AF et al (2020) Leishmania Immunity: advancing immunotherapy and vaccine development. Microorganisms 8(8):1201. https:\/\/doi.org\/10.3390\/microorganisms8081201","journal-title":"Microorganisms"},{"key":"620_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00670","author":"A Dayakar","year":"2019","unstructured":"Dayakar A, Chandrasekaran S, Kuchipudi SV, Kalangi SK (2019) Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.00670","journal-title":"Front Immunol"},{"key":"620_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.29252\/JoMMID.8.1.7","volume":"8","author":"S Hamoon Navard","year":"2020","unstructured":"Hamoon Navard S, Rezvan H, Feiz Haddad MH, Baghaban Eslaminejad M, Azami S (2020) Expression of cytokine genes in Leishmania major-infected BALB\/c mice treated with mesenchymal stem cells. J Med Microbiol Infect Dis 8:7\u201313.\u00a0https:\/\/doi.org\/10.29252\/JoMMID.8.1.7","journal-title":"J Med Microbiol Infect Dis"},{"key":"620_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jgar.2020.09.005","volume":"23","author":"SH Navard","year":"2020","unstructured":"Navard SH, Rezvan H, Haddad MHF, Ali SA, Nourian A, Eslaminejad MB et al (2020) Therapeutic effects of mesenchymal stem cells on cutaneous Leishmaniasis lesions caused by Leishmania major. J Glob Antimicrob Resist 23:243\u2013250. https:\/\/doi.org\/10.1016\/j.jgar.2020.09.005","journal-title":"J Glob Antimicrob Resist"},{"key":"620_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.imlet.2019.10.008","volume":"216","author":"E Zanganeh","year":"2019","unstructured":"Zanganeh E, Soudi S, Zavaran Hosseini A, Khosrojerdi A (2019) Repeated intravenous injection of adipose tissue derived mesenchymal stem cells enhances Th1 immune responses in Leishmania major-infected BALB\/c mice. Immunol Lett 216:97\u2013105. https:\/\/doi.org\/10.1016\/j.imlet.2019.10.008","journal-title":"Immunol Lett"},{"key":"620_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00893","author":"JC Pereira","year":"2017","unstructured":"Pereira JC, Ramos TD, Silva JD, de Mello MF, Pratti JES, da Fonseca-Martins AM et al (2017) Effects of bone marrow mesenchymal stromal cell therapy in experimental cutaneous Leishmaniasis in balb\/c mice induced by Leishmania amazonensis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.00893","journal-title":"Front Immunol"},{"issue":"1","key":"620_CR54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13287-020-01889-z","volume":"11","author":"TD Ramos","year":"2020","unstructured":"Ramos TD, Silva JD, da Fonseca-Martins AM, da Silveira Pratti JE, Firmino-Cruz L, Maciel-Oliveira D et al (2020) Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous Leishmaniasis caused by Leishmania amazonensis. Stem Cell Res Ther 11(1):374. https:\/\/doi.org\/10.1186\/s13287-020-01889-z","journal-title":"Stem Cell Res Ther"},{"key":"620_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2020.108063","author":"S Bahrami","year":"2021","unstructured":"Bahrami S, Safari M, Razi Jalali MH, Ghorbanpoor M, Tabandeh MR, Rezaie A (2021) The potential therapeutic effect of adipose-derived mesenchymal stem cells in the treatment of cutaneous Leishmaniasis caused by L. major in BALB\/c mice. Exp Parasitol. https:\/\/doi.org\/10.1016\/j.exppara.2020.108063","journal-title":"Exp Parasitol"},{"key":"620_CR56","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/b978-0-12-813712-3.00006-0","volume-title":"Human Parasitology","author":"BJ Bogitsh","year":"2019","unstructured":"Bogitsh BJ, Carter CE, Oeltmann TN (2019) Blood and Tissue Protistans I. In: Bogitsh BJ, Carter CE, Oeltmann TN (eds) Human Parasitology. Academic Press, Cambridge, pp 83\u2013110.\u00a0https:\/\/doi.org\/10.1016\/b978-0-12-813712-3.00006-0"},{"key":"620_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2019.00166","author":"KCF Lidani","year":"2019","unstructured":"Lidani KCF, Andrade FA, Bavia L, Damasceno FS, Beltrame MH, Messias-Reason IJ et al (2019) Chagas disease: from discovery to a worldwide health problem. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2019.00166","journal-title":"Front Public Health"},{"issue":"10115","key":"620_CR58","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/s0140-6736(17)31612-4","volume":"391","author":"JA P\u00e9rez-Molina","year":"2018","unstructured":"P\u00e9rez-Molina JA, Molina I (2018) Chagas disease. Lancet 391(10115):82\u201394. https:\/\/doi.org\/10.1016\/s0140-6736(17)31612-4","journal-title":"Lancet"},{"key":"620_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-030-00054-7_4","volume-title":"Birkh\u00e4user Advances in Infectious Diseases","author":"R Chuit","year":"2019","unstructured":"Chuit R, Meiss R, Salvatella R (2019) Epidemiology of Chagas Disease. Birkh\u00e4user Advances in Infectious Diseases. Springer, Berlin, pp 91\u2013109.\u00a0https:\/\/doi.org\/10.1007\/978-3-030-00054-7_4"},{"key":"620_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-00054-7_8","volume-title":"Acute Vector-Borne Chagas Disease. Birkh\u00e4user Advances in Infectious Diseases","author":"G Moscatelli","year":"2019","unstructured":"Moscatelli G, Moroni S (2019) Acute Vector-Borne Chagas Disease. Birkh\u00e4user Advances in Infectious Diseases. Springer, Berlin.\u00a0https:\/\/doi.org\/10.1007\/978-3-030-00054-7_8"},{"issue":"10","key":"620_CR61","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nrcardio.2012.109","volume":"9","author":"AL Ribeiro","year":"2012","unstructured":"Ribeiro AL, Nunes MP, Teixeira MM, Rocha MO (2012) Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol 9(10):576\u2013589. https:\/\/doi.org\/10.1038\/nrcardio.2012.109","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"620_CR62","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1586\/14779072.2015.1103648","volume":"13","author":"HB Tanowitz","year":"2015","unstructured":"Tanowitz HB, Machado FS, Spray DC, Friedman JM, Weiss OS, Lora JN et al (2015) Developments in the management of Chagas cardiomyopathy. Expert Rev Cardiovasc Ther 13(12):1393\u20131409. https:\/\/doi.org\/10.1586\/14779072.2015.1103648","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"620_CR63","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5500\/wjt.v3.i4.119","volume":"3","author":"KA de Carvalho","year":"2013","unstructured":"de Carvalho KA, Abdelwahid E, Ferreira RJ, Irioda AC, Guarita-Souza LC (2013) Preclinical stem cell therapy in Chagas Disease: Perspectives for future research. World J Transplant 3(4):119\u2013126. https:\/\/doi.org\/10.5500\/wjt.v3.i4.119","journal-title":"World J Transplant"},{"issue":"2","key":"620_CR64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1590\/s0066-782x2004000200010","volume":"82","author":"F Vilas-Boas","year":"2004","unstructured":"Vilas-Boas F, Feitosa GS, Soares MB, Pinho-Filho JA, Mota A, Almeida AJ et al (2004) Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas\u2019 disease. Arq Bras Cardiol 82(2):185\u2013187. https:\/\/doi.org\/10.1590\/s0066-782x2004000200010","journal-title":"Arq Bras Cardiol"},{"key":"620_CR74","doi-asserted-by":"publisher","unstructured":"Soares MB, Lima RS, Rocha LL, Takyia CM, Pontes-de-Carvalho L, de Carvalho AC et al (2004) Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. Am J Pathol 164(2):441\u2013447. https:\/\/doi.org\/10.1016\/s0002-9440(10)63134-3","DOI":"10.1016\/s0002-9440(10)63134-3"},{"issue":"1 Suppl","key":"620_CR65","doi-asserted-by":"publisher","first-page":"I120","DOI":"10.1161\/CIRCULATIONAHA.105.000646","volume":"114","author":"LC Guarita-Souza","year":"2006","unstructured":"Guarita-Souza LC, Carvalho KA, Woitowicz V, Rebelatto C, Senegaglia A, Hansen P et al (2006) Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation 114(1 Suppl):I120\u2013I124. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.000646","journal-title":"Circulation"},{"issue":"5","key":"620_CR66","doi-asserted-by":"publisher","first-page":"460","DOI":"10.5935\/abc.20130058","volume":"100","author":"TF Larocca","year":"2013","unstructured":"Larocca TF, Souza BS, Silva CA, Kaneto CM, Alcantara AC, Azevedo CM et al (2013) Transplantation of adipose tissue mesenchymal stem cells in experimental chronic chagasic cardiopathy. Arq Bras Cardiol 100(5):460\u2013468. https:\/\/doi.org\/10.5935\/abc.20130058","journal-title":"Arq Bras Cardiol"},{"issue":"8","key":"620_CR67","doi-asserted-by":"publisher","first-page":"e0003945","DOI":"10.1371\/journal.pntd.0003945","volume":"9","author":"DB Mello","year":"2015","unstructured":"Mello DB, Ramos IP, Mesquita FC, Brasil GV, Rocha NN, Takiya CM et al (2015) Adipose tissue-derived mesenchymal stromal cells protect mice infected with trypanosoma cruzi from cardiac damage through modulation of anti-parasite immunity. PLoS Negl Trop Dis 9(8):e0003945. https:\/\/doi.org\/10.1371\/journal.pntd.0003945","journal-title":"PLoS Negl Trop Dis"},{"key":"620_CR68","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1371\/journal.pntd.0001971","volume":"6","author":"Jasmin","year":"2012","unstructured":"Jasmin, Jelicks- LA, Koba W, Tanowitz HB, Mendez-Otero R, Campos de Carvalho AC et al (2012) Mesenchymal bone marrow cell therapy in a mouse model of chagas disease. Where do the cells go? PLoS Negl Trop Dis 6:1971. https:\/\/doi.org\/10.1371\/journal.pntd.0001971","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"620_CR69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/scrt470","volume":"5","author":"DN Silva","year":"2014","unstructured":"Silva DN, de Freitas Souza BS, Azevedo CM, Vasconcelos JF, Carvalho RH, Soares MB et al (2014) Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy. Stem Cell Res Ther 5(4):81. https:\/\/doi.org\/10.1186\/scrt470","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"620_CR70","doi-asserted-by":"publisher","first-page":"e9252","DOI":"10.1371\/journal.pone.0009252","volume":"5","author":"J Maggini","year":"2010","unstructured":"Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon IM, Nepomnaschy I et al (2010) Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS ONE 5(2):e9252. https:\/\/doi.org\/10.1371\/journal.pone.0009252","journal-title":"PLoS ONE"},{"issue":"11","key":"620_CR71","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.micinf.2014.08.016","volume":"16","author":"J LA Jasmin","year":"2014","unstructured":"LA Jasmin J, Tanowitz HB, Peters VM, Mendez-Otero R, de Carvalho ACC et al (2014) Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease. Microbes Infect 16(11):923\u2013935. https:\/\/doi.org\/10.1016\/j.micinf.2014.08.016","journal-title":"Microbes Infect"},{"key":"620_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01449","author":"DN Silva","year":"2018","unstructured":"Silva DN, Souza BSF, Vasconcelos JF, Azevedo CM, Valim CXR, Paredes BD et al (2018) Granulocyte-colony stimulating factor-overexpressing mesenchymal stem cells exhibit enhanced immunomodulatory actions through the recruitment of suppressor cells in experimental chagas disease cardiomyopathy. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.01449","journal-title":"Front Immunol"},{"key":"620_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9108681","volume":"2018","author":"DN Silva","year":"2018","unstructured":"Silva DN, Souza BSF, Azevedo CM, Vasconcelos JF, de Jesus PG, Feitoza MS et al (2018) IGF-1-Overexpressing mesenchymal stem\/stromal cells promote immunomodulatory and proregenerative effects in chronic experimental chagas disease. Stem Cells Int 2018:1\u201311. https:\/\/doi.org\/10.1155\/2018\/9108681","journal-title":"Stem Cells Int"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-022-00620-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-022-00620-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-022-00620-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T02:29:26Z","timestamp":1669688966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-022-00620-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1007\/s11686-022-00620-7","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable to this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}